Last reviewed · How we verify
NCT06933680
Sphenopalatine Ganglion Block in Bimaxillary Orthognathic Surgery
NA trial testing Sphenopalatine Ganglion Block in Bimaxillar Surgery in 50 participants. Currently enrolling.
1 May 2025
Quick facts
| Lead sponsor | Bezmialem Vakif University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 50 |
| Start date | 25 June 2024 |
| Primary completion | 1 May 2025 |
| Estimated completion | 15 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Sphenopalatine Ganglion Block — full drug profile →
- Sham Block — full drug profile →
Conditions studied
- Bimaxillar Surgery — all drugs for Bimaxillar Surgery →
- Sphenopalatine Ganglion Block — all drugs for Sphenopalatine Ganglion Block →
Sponsor
Bezmialem Vakif University
Who can join
Adults 18 to 45, any sex, with Bimaxillar Surgery or Sphenopalatine Ganglion Block. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate whether sphenopalatine ganglion (SPG) block helps with intraoperative pain control, reduces postoperative edema, and decreases pain in adults aged 18 to 45 undergoing bimaxillary orthognathic surgery. The main questions it aims to answer are: * Does SPG block help decrease postoperative swelling and pain compared to a sham block? * Does it improve pain control during surgery and reduce opioid use? Researchers will compare patients receiving SPG block to those receiving a sham block to determine if this technique provides better pain relief and reduces postoperative complications. Participants will: * Be 18 to 45 years old and undergo bimaxillary orthognathic surgery. * Be randomly assigned to receive either a SPG block or a sham block before surgery. * Be monitored for 1 month after surgery to assess pain levels, swelling, opioid use, and possible complications.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06933680
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sphenopalatine Ganglion Block
Trials testing the same drug.
- NCT07060586 — The Effect of Sphenopalatine Ganglion Block on Headache and Vasalgia · NA · completed
- NCT06157970 — Sphenopalatine Ganglion Block in Septorhinoplasty · completed
- NCT04657952 — Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients · Phase 4 · unknown
- NCT02517931 — Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department · NA · withdrawn
Other Bezmialem Vakif University trials
Trials by the same sponsor.
- NCT07369297 — PULP SENSIBILITY AND MASSETER INHIBITORY REFLEX IN DIABETIC POLYNEUROPATHY · not yet recruiting
- NCT07433595 — Association Between Child and Parental Stress and Bruxism in Children Aged 8-11 Years · not yet recruiting
- NCT07443111 — Comparison of Virtual Reality-Based and Routine Preoperative Education on Surgical Anxiety and Salivary Cortisol · NA · not yet recruiting
- NCT07421349 — Comparison of Pulmonary Functions and Respiratory Muscle Strength Between Children With Hearing Impairment and Healthy P · not yet recruiting
- NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06933680 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bezmialem Vakif University
- Last refreshed: 18 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06933680.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing